We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.

Global Molecular Diagnostics Market

The global Molecular Diagnostics Market was valued at USD 6.12 billion in 2016 and is projected to reach USD 12.93 billion by 2025, growing at a CAGR of 8.67% from 2017 to 2025.

Molecular diagnostics is a combination of techniques used to analyze biological markers in the genome and proteome, genetic code and cells expression in terms of gene as proteinsâ€"by applying molecular biology to medical testing.

Sample Infographics:



Market Dynamics:
1. Market Drivers
1.1 Increasing oncology studies and cancer patients
1.2 Growing demand of personalized medicines
1.3 Growing Market of molecular biology and biomarker techniques in healthcare
1.4 Assured reimbursements

2. Market Restraints
2.1 Stringent regulations

Market Segmentation:
1. Global Molecular Diagnostics Market, by Technology:
1.1 Polymerase Chain Reaction (PCR)
1.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.3 Hybridization (In-Situ Hybridization & Fish)
1.4 DNA Sequencing and Next-Generation Sequencing
1.5 Microarray
1.6 Other Technologies

2. Global Molecular Diagnostics Market, by Application:
2.1 Infectious Diseases
2.1.1 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
2.1.2 Hepatitis B
2.1.3 Human Papillomavirus (HPV)
2.1.4 Human Immunodeficiency Virus (HIV)
2.1.5 Tuberculosis (TB)
2.1.6 Hepatitis C
2.1.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
2.1.8 Other Infectious Diseases
2.2 Oncology
2.2.1 Breast Cancer
2.2.2 Colorectal Cancer
2.2.3 Prostate Cancer
2.2.4 Other Cancers
2.3 Blood Screening
2.4 Genetic Tests
2.5 Microbiology
2.6 Other Applications

3. Global Molecular Diagnostics Market, by End User:
3.1 Hospital and Academic Laboratories
3.2 Reference Laboratories
3.3 Other End Users

4. Global Molecular Diagnostics Market, by Products and Services:
4.1 Reagents & Kits
4.2 Instruments
4.3 Software & Services

5. Global Molecular Diagnostics Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Abbott Laboratories
2. Qiagen N.V.
3. Roche Diagnostics
4. Hologic, Inc.
5. Grifols
6. Siemens Healthcare
7. Becton, Dickinson and Company
8. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
9. Biomérieux Sa
10. Cepheid Inc.

These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Molecular Diagnostics Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

1 INTRODUCTION OF GLOBAL MOLECULAR DIAGNOSTICS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL MOLECULAR DIAGNOSTICS MARKET OUTLOOK
4.1 Overview

4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities

4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 Global Molecular Diagnostics Market, by Technology:
5.1 Polymerase Chain Reaction (PCR)
5.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
5.3 Hybridization (In-Situ Hybridization & Fish)
5.4 DNA Sequencing and Next-Generation Sequencing
5.5 Microarray
5.6 Other Technologies

6 Global Molecular Diagnostics Market, by Application:
6.1 Infectious Diseases
6.1.1 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
6.1.2 Hepatitis B
6.1.3 Human Papillomavirus (HPV)
6.1.4 Human Immunodeficiency Virus (HIV)
6.1.5 Tuberculosis (TB)
6.1.6 Hepatitis C
6.1.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
6.1.8 Other Infectious Diseases

6.2 Oncology
6.2.1 Breast Cancer
6.2.2 Colorectal Cancer
6.2.3 Prostate Cancer
6.2.4 Other Cancers

6.3 Blood Screening
6.4 Genetic Tests
6.5 Microbiology
6.6 Other Applications

7 Global Molecular Diagnostics Market, by End User:
7.1 Hospital and Academic Laboratories
7.2 Reference Laboratories
7.3 Other End Users

8 Global Molecular Diagnostics Market, by Products and Services:
8.1 Reagents & Kits
8.2 Instruments
8.3 Software & Services

9 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY GEOGRAPHY
9.1 Overview

9.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico

9.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe

9.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific

9.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025

10 GLOBAL MOLECULAR DIAGNOSTICS MARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 Abbott Laboratories
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 Qiagen N.V.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 Roche Diagnostics
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Hologic, Inc.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 Grifols
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 Siemens Healthcare
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 Becton, Dickinson and Company
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Beckman Coulter Inc.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Biomérieux Sa
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments

11.10 Cepheid Inc.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments

12 Appendix
12.1 Related Reports

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved